(NYSE:MYL) announced today that the U. We assume no obligation to update any forward-looking statements presented here today, whether as a result of new information, future events or otherwise. Business Editors & Health/Medical Writers Able Laboratories, 50mg ultram inc. Received Food and Drug Administration approval to market fluoxetine hydrochloride in 10 mg and 20 mg capsules. To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking statements regarding our anticipated financial results and estimates, business prospects and products 50mg ultram in research and under going development, all of which involve substantial risks and uncertainties. (Nasdaq: TEVA) announced today that the U. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the beliefs and expectations of management. Ultram(R) Tablets is a registered trademark of Johnson & Johnson. Business Editors & Medical Writers Eon Labs, 50mg ultram inc. Forward-looking statements are merely the Company’s current predictions of future events. 17, 2002 Teva Pharmaceutical Industries Ltd. Securities and Exchange Commission. Important factors that could cause or contribute to such regulatory environment and changes in the health policies and structure of various countries, acceptance and demand for new pharmaceutical products and new therapies, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, uncertainties regarding market acceptance of innovative products newly launched, currently being sold or in development, the impact of restructuring 50mg ultram of clients, reliance on a strategy of acquiring companies and on strategic alliances, exposure to product liability claims, dependence on patent and other protections for our innovative products, fluctuations in currency, exchange and interest rates, operating results, and other factors that are discussed in the Company’s Annual Report on Form 20-F and the Company’s other filings with the U. Mutual also received preliminary approval for tramadol 50 mg tablets, the 50mg ultram generic version of the pain killer Ultram. Business 50mg ultram editors JERUSALEM, Israel–(BUSINESS WIRE)–June 20, 2002 Teva Pharmaceutical Industries Ltd. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks and uncertainties that could cause the Company’s future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. IVAX Corporation, headquartered in Miami, 50mg ultram florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U. The statements are inherently uncertain, and actual results could differ 50mg ultram materially from the statements made herein. The company is continuing its aggressive filing schedule for new ANDA submissions. Under the terms of the agreement, Able Labs will manufacture and supply the product exclusively to IVAX under their label and IVAX will exclusively sell Able Labs’ manufactured product. The company develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients.